Senator Cassidy's report blames FDA for lax oversight of abortion pill manufacturers
Senator Bill Cassidy released a report accusing the Food and Drug Administration of failing to tighten restrictions on the abortion pill mifepristone and of lacking transparency in its oversight.
The investigation, conducted by Cassidy and other Republicans on the Senate health committee, targets Danco, the distributor of the brand-name product, and two generic manufacturers, alleging the agency redacts mifepristone-related records.
The findings add pressure to the pending confirmation of FDA commissioner Heidi Overton and echo GOP calls for the Trump administration to rein in the drug.
This writeup was produced by pharmadog from original reporting by STAT.
Original headline: “STAT+: Cassidy criticizes FDA oversight of abortion pill manufacturers in new report”
read at STAT ↗
comments(0)
5-min edit window · permanent after that